1Team Manager, Infection Control Office, Mokpo Christian Hospital, Jeollanam-do, Korea
2Professor, Department of Nursing, Mokpo National University, Jeollanam-do, Korea
Copyright © 2023 Korean Academy of Community Health Nursing
This is an Open Access article distributed under the terms of the Creative Commons Attribution NoDerivs License. (http://creativecommons.org/licenses/by-nd/4.0) which allows readers to disseminate and reuse the article, as well as share and reuse the scientific material. It does not permit the creation of derivative works without specific permission.
Conflict of interest
The authors declared no conflict of interest.
Funding
None.
Authors’ contributions
Kim, Nam-Sook contributed to conceptualization, methodology, project administration, visualization, writing-original draft, and investigation. Choi, So-Eun contributed to conceptualization, data curation, formal analysis, methodology, writing-review-editing, and supervision.
Data availability
Please contact the corresponding author for data availability.
MDROs=Multidrug-resistant organisms; VRSA=Vancomycin–resistant Staphylococcus aureus; MRSA=Methicillin–resistant Staphylococcus aureus; VRE=Vancomycin–resistant Enterococci; CRE=Carbapenem–resistant Enterobacteriaceae; MRPA=Multidrug- resistant Pseudomonas aeruginosa; MRAB=Multidrug- resistant Acinetobacter baumannii
Characteristics | Categories | n(%) | Attitude | Subjective norms | Perceived behavior control | Intention | Performance | |||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
M±SD | t or F (p) | M±SD | t or F (p) | M±SD | t or F (p) | M±SD | t or F (p) | M±SD | t or F (p) | |||
Gender | Male | 19(18.1) | 6.13±0.88 | 0.70 | 6.55±0.66 | 0.33 | 5.36±1.33 | -0.96 | 5.51±1.32 | -0.89 | 4.30±0.50 | -1.46 |
Female | 86(81.9) | 5.94±1.10 | (.487) | 6.50±0.61 | (.740) | 5.67±0.87 | (.347) | 5.79±0.89 | (.385) | 4.47±0.45 | (.147) | |
Age(year) | 22-24 | 24(22.9) | 6.09±0.95 | 0.27 | 6.44±0.45 | 1.31 | 5.61±0.91 | 3.10 | 5.89±0.90 | 1.90 | 4.33±0.48 | 1.38 |
25-29 | 48(45.7) | 5.87±1.17 | (.846) | 6.43±0.77 | (.276) | 5.50±1.01 | (.030) | 5.54±1.08 | (.134) | 4.43±0.48 | (.253) | |
30-34 | 15(14.3) | 6.03±1.25 | 6.63±0.44 | 6.27±0.67 | 6.18±0.59 | 4.63±0.38 | ||||||
≥35 | 18(17.1) | 6.03±0.80 | 6.72±0.43 | 5.34±0.98 | 5.70±0.96 | 4.47±0.42 | ||||||
Education level | College | 24(22.9) | 5.98±1.35 | 0.06 | 6.42±0.76 | -0.83 | 5.61±1.09 | -0.01 | 5.88±1.14 | 0.77 | 4.46±0.48 | 0.20 |
Bachelor | 81(77.1) | 5.97±0.98 | (.951) | 6.54±0.57 | (.406) | 5.61±0.94 | (.995) | 5.70±0.93 | (.443) | 4.44±0.46 | (.839) | |
Clinical career(year) | <1 | 27(25.7) | 6.23±0.78 | 1.09 | 6.56±0.45 | 1.30 | 5.73±0.96 | 0.61 | 5.94±1.03 | 1.05 | 4.34±0.50 | 1.25 |
1≤y<5 | 43(41.0) | 5.82±1.11 | (.356) | 6.37±0.79 | (.277) | 5.46±1.01 | (.612) | 5.55±1.00 | (.376) | 4.52±0.40 | (.297) | |
5≤y< 10 | 21(20.0) | 5.83±1.48 | 6.64±0.45 | 5.72±0.95 | 5.76±0.99 | 4.37±0.54 | ||||||
≥10 | 14(13.3) | 6.16±0.53 | 6.64±0.50 | 5.69±0.94 | 5.90±0.76 | 4.52±0.41 | ||||||
Current position career(year) | <1 | 31(29.5) | 6.15±0.93 | 0.55 | 6.53±0.45 | 2.88 | 5.75±0.96 | 0.91 | 5.88±0.99 | 0.57 | 4.34±0.49 | 1.03 |
1≤y<3 | 32(30.5) | 5.86±1.08 | (.653) | 6.27±0.86 | (.040) | 5.41±1.02 | (.437) | 5.59±1.04 | (.638) | 4.55±0.42 | (.384) | |
3≤y<5 | 14(13.3) | 5.80±1.04 | 6.71±0.38 | 5.50±0.90 | 5.62±0.88 | 4.43±0.41 | ||||||
≥5 | 28(26.7) | 5.99±1.22 | 6.66±0.47 | 5.74±0.97 | 5.81±0.96 | 4.44±0.50 | ||||||
Position | Staff nurse | 91(86.7) | 5.94±1.13 | -0.33 | 6.49±0.64 | -0.05 | 5.60±0.98 | -0.22 | 5.71±1.01 | 0.02 | 4.43±0.47 | -0.52 |
Charge nurse | 14(13.3) | 6.08±0.58 | (.744) | 6.50±0.53 | (.962) | 5.68±1.02 | (.287) | 5.71±0.52 | (.987) | 4.50±0.39 | (.605) | |
Experience of MDROs infection control education | Yes | 89(84.8) | 5.93±1.10 | -1.03 | 6.52±0.63 | 0.28 | 5.58±1.00 | -0.74 | 5.76±0.97 | 0.51 | 4.45±0.46 | 0.59 |
No | 16(15.2) | 6.23±0.84 | (.304) | 6.47±0.59 | (.777) | 5.78±0.81 | (.462) | 5.63±1.04 | (.613) | 4.38±0.47 | (.559) | |
Satisfied with the application of MDROs infection control guidelines | Satisfied | 92(87.6) | 5.95±1.12 | -0.44 | 6.49±0.64 | -0.90 | 5.66±0.97 | 1.39 | 5.79±1.01 | 1.51 | 4.47±0.46 | 1.67 |
Unsatisfied | 13(12.4) | 6.09±0.58 | (.665) | 6.65±0.47 | (.373) | 5.26±0.94 | (.169) | 5.36±0.58 | (.135) | 4.24±0.48 | (.098) |
Variables | Mean±SD | Min-Max | Possible range |
---|---|---|---|
Attitude | 5.97±1.07 | 1.00-7.00 | 1-7 |
Subjective norm | 6.51±0.62 | 3.50-7.00 | 1-7 |
Perceived behavior control | 5.61±0.97 | 3.20-7.00 | 1-7 |
Intention | 5.74±0.98 | 3.00-7.00 | 1-7 |
Behavior | 4.44±0.46 | 3.00-5.00 | 1-5 |
Attitude | Subjective norm | Perceived behavior control | Intention | Behavior | |
---|---|---|---|---|---|
r (p) | r (p) | r (p) | r (p) | r (p) | |
Attitude | 1 | ||||
Subjective norm | .20 | 1 | |||
(.038) | |||||
Perceived behavior control | .16 | .35 | 1 | ||
(.115) | (<.001) | ||||
Intention | .11 | .38 | .67 | 1 | |
(.274) | (<.001) | (<.001) | |||
Behavior | -.00 | .24 | .53 | .54 | 1 |
(.983) | (.012) | (<.001) | (<.001) |
Models | B | SE | β | t | p | R² | AdjR² | F | p | |
---|---|---|---|---|---|---|---|---|---|---|
Step 1 | Subjective norm → Intention | 0.61 | 0.14 | .38 | 4.23 | <.001 | .15 | .14 | 17.87 | <.001 |
Step 2 | Subjective norm → Behavior | 0.18 | 0.07 | .24 | 2.55 | .012 | .06 | .05 | 6.5 | 0.012 |
Step 3 | Subjective norm → Behavior | 0.03 | 0.07 | .04 | 0.47 | .637 | .29 | .28 | 21.03 | <.001 |
Intention → Behavior | 0.25 | 0.04 | .52 | 5.79 | <.001 | |||||
Sobel test: z=3.57, p<.001 | ||||||||||
Step 1 | Perceived behavior control → Intention | 0.68 | 0.07 | .67 | 9.21 | <.001 | .45 | .45 | 84.73 | <.001 |
Step 2 | Perceived behavior control → Behavior | 0.25 | 0.04 | .53 | 6.32 | <.001 | .28 | .27 | 39.88 | <.001 |
Step 3 | Perceived behavior control → Behavior | 0.14 | 0.05 | .30 | 2.79 | .006 | .34 | .33 | 26.37 | <.001 |
Intention → Behavior | 0.16 | 0.05 | .34 | 3.09 | .003 | |||||
Sobel test: z=3.04, p<.001 |
MDROs=Multidrug-resistant organisms; VRSA=Vancomycin–resistant